Jeannie Woith Discusses the Benefits of Low-Level Laser Therapy for Oral Mucositis

Article

Jeannie Woith, BSN, RN, LMT, The James Cancer Hospital, The Ohio State University, discusses the benefits of treating oral mucositis with low-level laser therapy.

Jeannie Woith, BSN, RN, LMT, The James Cancer Hospital, The Ohio State University, discusses the benefits of treating oral mucositis with low-level laser therapy.

Recent Videos
Image of Pattie Jakel, MN, RN, AOCN, in front of a blue watercolor Oncology Nursing News backdrop
Image of Jessie Desir, PhD, RN, AMB-BC, OCN, in a video call with a blue and gold Oncology Nursing News border surrounding the frame.
Image of Jessie Desir, PhD, RN, AMB-BC, OCN, in a video call with a blue and gold Oncology Nursing News border surrounding the frame.
Related Content
Line illustration of a head, including the nasal cavity, mouth and throat on a gold background.

PYX-201 Receives FDA Fast Track Designation for Recurrent/Metastatic HNSCC

Caroline Seymour
March 8th 2025
Article

The FDA has granted PYX-201 fast track designation for treatment of recurrent or metastatic HNSCC after progression post-chemoimmunotherapy.

Shawna Douglas On How Nurse Navigators Help Ease the Treatment Burden for Patients With Head and Neck Cancer

Shawna Douglas On How Nurse Navigators Help Ease the Treatment Burden for Patients With Head and Neck Cancer

Lindsay Fischer
September 1st 2023
Podcast

Shawna Douglas, BSN, RN, discusses the role that nurse navigators play in caring for patients with head and neck cancer.

White line illustration of the head and neck, including the nasal cavity and throat, on a cornflower blue background

Petosemtamab/Pembrolizumab Receives FDA Breakthrough Designation for PD-L1+ HNSCC

Chris Ryan
February 28th 2025
Article

The FDA granted petosemtamab plus pembrolizumab breakthrough therapy status for PD-L1–positive recurrent/metastatic head and neck squamous cell carcinoma.

Simple line illustration of a thyroid against a dark blue background

Thyroidectomy Without Radioiodine May Be Noninferior to Radioiodine Use in Thyroid Cancer

Roman Fabbricatore
February 6th 2025
Article

More excellent responses occurred for patients with low-risk thyroid cancer who had thyroidectomies without radioiodine vs treatment with radioiodine.

green background with FDA in blue text and approved with a checkmark in darker green text

FDA OKs Subcutaneous Nivolumab in Advanced/Metastatic Solid Tumors

Chris Ryan
December 27th 2024
Article

Nivolumab and hyaluronidase-nvhy (Opdivo Qvantig) was approved by the FDA for subcutaneous injection across approved solid tumor indications for nivolumab (Opdivo).

Head and Neck Cancer

NCCN Updates Guidelines for Preferred Frontline Regimen for Advanced Nasopharyngeal Carcinoma

Chris Ryan
December 5th 2024
Article

The NCCN Guidelines Version 1.2025 for Cancer of the Nasopharynx listed toripalimab plus chemotherapy as the standalone preferred regimen in the frontline treatment of patients with advanced nasopharyngeal carcinoma.